ryzodeg penfill solution injectable
novo nordisk pharma ag - insulinum degludecum, insulinum aspartum - solution injectable - insulinum degludecum 420 nmol corresp. insulinum degludecum 70 u., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 u., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
ryzodeg flextouch solution injectable
novo nordisk pharma ag - insulinum degludecum, insulinum aspartum - solution injectable - insulinum degludecum 420 nmol corresp. insulinum degludecum 70 u., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 u., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
awiqli flextouch 700 e/ml solution injectable en stylo prérempli
novo nordisk pharma ag - insulinum icodecum - solution injectable en stylo prérempli - insulinum icodecum 700 u., zincum ut zinci acetas, phenolum, metacresolum, glycerolum, natrii chloridum, acidum hydrochloridum ad ph, natrii hydroxidum ad ph, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.46 mg. - behandlung des diabetes mellitus bei erwachsenen. - biotechnologika
xultophy insulin degludec 100 e/ml und liraglutide 3.6 mg/ml solution injectable
novo nordisk pharma ag - insulinum degludecum, liraglutidum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète de l'adulte - biotechnologika
insulin novonordisk levemir 100 e/ml penfill solution injectable
novo nordisk pharma ag - insulinum detemirum - solution injectable - insulinum detemirum 100 u., natrii chloridum, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 2.06 mg, phenolum 1.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk levemir 100 e/ml flexpen solution injectable
novo nordisk pharma ag - insulinum detemirum - solution injectable - insulinum detemirum 100 u., natrii chloridum, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 2.06 mg, phenolum 1.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
bocouture 4 u - 0.1 ml sol. inj. (pdr.) i.m. flac.
merz pharmaceuticals gmbh - toxine clostridium botulinum , type a - poudre pour solution injectable - 4 u - 0,1 ml - toxine clostridium botulinum , type a 40 u/ml - botulinum toxin
xeomeen 50 u sol. inj. (pdr.) i.m. flac.
merz pharmaceuticals gmbh - toxine clostridium botulinum , type a - poudre pour solution injectable - 50 u - toxine clostridium botulinum , type a 50 u - botulinum toxin
xeomeen 100 u sol. inj. (pdr.) i.m. flac.
merz pharmaceuticals gmbh - toxine clostridium botulinum , type a - poudre pour solution injectable - 100 u - toxine clostridium botulinum , type a 100 u - botulinum toxin
xeomeen 200 u sol. inj. (pdr.) i.m. flac.
merz pharmaceuticals gmbh - toxine clostridium botulinum , type a - poudre pour solution injectable - 200 u - toxine clostridium botulinum , type a 200 u - botulinum toxin